✦ LIBER ✦

Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer

✍ Scribed by James N. Ingle; John F. Foley; James A. Mailliard; James E. Krook; Lynn C. Hartmann; Sin-Ho Jung; Michael H. Veeder; Dean H. Gesme Jr; Alan K. Hatfield; Richard M. Goldberg

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 611 KB
Volume: 73
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940501)73:9<2337::aid-cncr2820730916>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low dose chemotherapy of metastatic brea

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin

✍ Richard H. Creech; Robert B. Catalano; David T. Harris; Paul F. Engstrom; Paul J 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Adjuvant chemotherapy with fluorouracil,

Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer a prospective randomized trial

✍ Aman U. Buzdar; George R. Blumenschein; Terry L. Smith; Kimberly C. Powell; Gabr 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

Between May 1977 and April 1980, 238 patients with operable breast cancer were treated with adjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) chemotherapy. All patients were randomized to receive FAC alone or FAC with nonspecific immunotherapy with Bacillus Calmette-Guerin (BCG) vaccine

A comparison of cyclophosphamide, adriam

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. A southeastern cancer study group project

✍ R. V. Smalley; J. Carpenter; A. Bartolucci; C. Vogel; S. Krauss 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Adjuvant doxorubicin and cyclophosphamid

Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node positive breast carcinoma : Results of a randomized controlled trial

✍ Soo-Mee Bang; Dae Seog Heo; Ki Hyeong Lee; Jae Ho Byun; Heung Moon Chang; Dong-Y 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Randomized clinical trial of CFP versus

Randomized clinical trial of CFP versus CMFP in women with metastatic breast cancer

✍ Robert F. Marschke JR.; James N. Ingle; Daniel J. Schaid; James E. Krook; James 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

A randomized trial was performed to determine relative efficacy and toxicity of two first-line combination chemotherapy regimens in women with metastatic breast cancer: CFP (cyclophosphamide, 5-fluorouracil, prednisone) and C M F P (cyclophosphamide, 5-fluorouracil, methotrexate, prednisone). Both r

Effect of c-erbB2 and estrogen receptor

Effect of c-erbB2 and estrogen receptor status on survival of women with primary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil

✍ David W. Miles; William H. Harris; Cheryl E. Gillett; Paul Smith; Diana M. Barne 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 2 views